Imaging

Bayer teams up with Huma to apply AI to lung cancer diagnosis

A research project between Bayer and digital health company Huma will use artificial intelligence to detect lung cancer in CT scans – and determine which type a patient has, in order to direct treatment. AI is already being applied by a number of groups, with some studies indicating it can even be more effective than …

Bayer teams up with Huma to apply AI to lung cancer diagnosis Read More »

AI ‘could help diagnose lung cancer a year earlier’

An artificial intelligence algorithm was able to detect signs of lung cancer on CT scans a year earlier than with traditional methods, according to a new study. CT (computed tomography) scans are already used to spot signs of lung tumours, followed by a biopsy or surgery to confirm whether the tumour is malignant, according to …

AI ‘could help diagnose lung cancer a year earlier’ Read More »

AI breast cancer screening ‘not accurate enough to replace humans’

There is not enough evidence yet to allow artificial intelligence based breast cancer detection to be fully integrated into screening services, says a UK study. The analysis of a dozen studies of AI-powered image recognition software for breast cancer screening – published in the British Medical Journal – has found that the technology isn’t yet …

AI breast cancer screening ‘not accurate enough to replace humans’ Read More »

J&J lung cancer initiative will use Optellum’s ‘digital biomarker’ tech

Three years ago, Johnson & Johnson set up a wide-ranging initiative with Boston University to try to improve lung cancer survival rates through prevention and early intervention. Now, its calling on artificial intelligence specialist Optellum to help with that effort. UK-based Optellum has developed an AI-powered clinical decision support – called Virtual Nodule Clinic – …

J&J lung cancer initiative will use Optellum’s ‘digital biomarker’ tech Read More »

Abbott bags FDA okay for AI-based heart imaging software

The FDA has approved an artificial intelligence-based imaging software developed by Abbott that is used to help physicians carry out procedures like implanting stents to open up narrowed blood vessels in the heart.  Abbott‘s Ultreon software is billed as a first-of-its-kind platform that is designed to be used with optical coherence tomography (OCT), an imaging …

Abbott bags FDA okay for AI-based heart imaging software Read More »

Disney characters will lend a hand to kids during MRI scans

Radiologists in Europe could soon have help keeping children calm as they have MRI scans from Disney favourites like Micky Mouse, Winnie the Pooh and the Little Mermaid. Healthcare tech company Philips has teamed up with Walt Disney Corp to develop custom ambient animations – featuring some of the most-lived characters from Disney, Marvel and …

Disney characters will lend a hand to kids during MRI scans Read More »

Pfizer deal paves way for approval of ImaginAb’s cancer imaging tech

ImaginAb has signed a deal with Pfizer, which it hopes will help it to gather information necessary for approval of its tumour imaging agent as a medical device in markets in the US and other countries. The California-based company has signed a non-exclusive license with Pfizer to supply its 89Zr CD8 Immuno-PET agent, which can …

Pfizer deal paves way for approval of ImaginAb’s cancer imaging tech Read More »

Roche, Blueprint raise pressure on Lilly with new Gavreto approval

The FDA has cleared Roche and Blueprint Medicine’s Gavreto for a new use in RET-mutated thyroid cancer, putting it on a level playing field with Eli Lilly’s rival therapy Retevmo. The US regulator says Gavreto (pralsetinib) can be used to treat patient aged over 12 with advanced or metastatic RET-mutant thyroid tumours, adding to its …

Roche, Blueprint raise pressure on Lilly with new Gavreto approval Read More »

Genentech Collaborates with Imbio to Develop Imaging Diagnostics for Lung Diseases

Shots: The agreement leverages Imbio’s technical, regulatory & commercial expertise to build medical imaging AI technology for use in research, clinical trials & clinical practice The focus of the agreement is to develop quantitative imaging diagnostics for lung diseases and to bring unique solutions for pulmonary imaging. The collaboration integrates Imbio’s expertise in imaging biomarkers …

Genentech Collaborates with Imbio to Develop Imaging Diagnostics for Lung Diseases Read More »